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DOI: 10.1039/c0ja00075bMany proteins (more than one third) contain metal ions either within their own structures or bound to
some of their active sites. These metals are involved in numerous biological processes and therefore, the
quantification of metalloproteins that can serve as clinical biomarkers is of great interest. With this aim,
the development of analytical strategies that permit individual (targeted) protein quantitative analysis
is attempted in this work. In particular, the evaluation of different strategies for the determination of
Cu, Zn-superoxide dismutase (Cu, Zn-SOD), a metalloprotein present in the first-line antioxidant
defence system of the body, is conducted. The first analytical strategy is based on the use of bovine Cu,
Zn-SOD as internal standard for the quantitative analysis of human Cu, Zn-SOD. For this aim, the
chromatographic separation between both species (bovine and human) has been optimized according
to their respective isoelectric point by anion exchange chromatography. Interestingly, the obtained
results revealed a faster specific degradation of the bovine standard with respect to human SOD during
sample preparation. The second strategy involves the production and evaluation of an isotopically
enriched metalloprotein standard to be used as tracer in the species specific isotope dilution (SS-IDA)
method by measuring the Cu associated to the protein. This is done by liquid chromatography with
online inductively coupled plasma mass spectrometric (ICP-MS) detection and applied to the
quantification in bovine erythrocytes. This finding is a good example to illustrate the power of SS-IDA
for targeted protein quantification in respect to the commonly used alternative standards.Introduction
A first step towards the molecular understanding of the patho-
genic mechanism of oxidative stress in different diseases is to
know the causing molecules of such redox imbalance or/and
evaluate their consequences. The most plausible cause for
oxidative stress is the presence of free radicals1 and there are
some intrinsic difficulties in their direct measurement: i) the ultra-
short half-life of these species (usually microseconds) due to their
high reactivity and ii) many of the generated end products are in
themselves reactive, although to a lesser degree. Therefore, the
measurement of the effects caused by free radical action is the
preferred way to evaluate oxidative stress. Among the different
possible biomarkers for oxidative stress, the measurement of
changes on the expression of redox controlling enzymes such asaDepartment of Physical and Analytical Chemistry, University of Oviedo,
C/Julian Claverıa 8, 33006 Oviedo, Spain. E-mail: eblancog@uniovi.es;
asm@uniovi.es
bCollege of Physical Science, Department of Chemistry, University of
Aberdeen, Meston Walk, Aberdeen, UK AB24 3UE
† This article is part of a themed issue highlighting outstanding and
emerging work in the area of speciation.
‡ Electronic supplementary information (ESI) available: Supplementary
information. See DOI: 10.1039/c0ja00075b
150 | J. Anal. At. Spectrom., 2011, 26, 150–155Cu, Zn-superoxide dismutase (SOD1; EC 1.15.1.1) are widely
used. Additionally, point mutations in this protein and the
presence of oxidative adducts are considered as specific
biomarkers Alzheimer’s disease (AD),2 Parkinson’s disease (PD)3
and amyotrophic lateral sclerosis (ALS).4 Cu, Zn-SOD is
a homodimeric enzyme (32 kDa) first discovered by McCord and
Friedovic,5 that catalyzes the dismutation of superoxide radicals
into molecular oxygen and hydrogen peroxide, which is then
decomposed by catalase and glutathione peroxidase. The
dismutation reaction takes place via its Cu ion redox cycle
[Cu-(II)/Cu(I)], while the neighboring Zn ion plays a structural
role.6
Thus, Cu, Zn-SOD has been established as one of the impor-
tant target biomolecules to address changes in the redox status of
the organisms and to protect for oxidative stress.7 However, this
can only be applied for clinical monitoring if sensitive and
specific methods for Cu, Zn-SOD determination exist to quan-
titatively distinguish between true disease values clearly
discriminated from the noise of individual biological variations.
Such quantitative targeted protein analysis is generally con-
ducted by combination of stable isotope dilution with multiple
reaction monitoring (MRM) via electrospray mass spectrometry
(ESI-MS).8 However, the determination of Cu, Zn-SOD inThis journal is ª The Royal Society of Chemistry 2011
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View Onlinebiological samples has been generally accomplished by activity
assays due to the relatively high concentration of this protein
reported in red blood cells (>20 mg L1, ranging between 20 and
240 mg L1).9,10 The levels found in serum (>100 mg L1) require
more sensitive and specific strategies such as ELISA assays that
provide limits of detection low enough (about 40 ng L1) to
address small variations among individuals.11,12 In any case, the
variation of the published concentration results among different
methods is so extensive that no reference levels of Cu, Zn-SOD
have been established yet either in serum or in red blood cells.
Additionally, variations due to different pathological conditions
can led to an increase of this biomarker (in, e.g. acute myeloge-
nous leukemia or renal failure where concentration in plasma can
increase from 54  21 ng mL1 in plasma to 354  125 ng
mL1).13 Also, a decrease in SOD levels (in e.g., malignant
lymphoma patients, chronic alcoholism or medullar tumours
where the concentration decreases from 353  62 ng g1 in
normal tissues to 123  13 ng mL1) can be observed.14,15
In addition to biological methods, some other alternatives
have been recently proposed with the final aim of Cu, Zn-SOD
absolute quantification by inductively coupled plasma mass
spectrometric (ICP-MS) consisting of determining the Cu bound
to the biomolecule and calculating the protein content from the
known metal:protein stoichiometry. Some of these strategies are
based on the appropriate gel electrophoretic separation of the
protein followed by the elemental detection of the Cu and Zn on
the ablated protein spots by ICP-MS.16 In order to compensate
for potential losses during the analytical procedure, Feldmann
et al. have used the synthesized isotopically labelled 65Cu,68Zn-
SOD that permits also the absolute quantification of the
protein.17,18 But the use of isotopically labelled protein standards
represents a growing area of research in both molecular (labelling
on the N, O or C)19 and elemental (labelling on the hetero-
elements such as Fe,20,21 Cu,22 etc.) mass spectrometry. It is well
established that the earlier in the procedure the isotopically
labelled species are spiked into the sample, the higher the
potential to compensate for metal losses during the whole
analytical procedure, independently if the final measurement is
done by ESI-MS or by ICP-MS.23
In a recent publication we have described the use of anion
exchange high performance liquid chromatography (HPLC) with
ICP-MS detection for Cu, Zn-SOD quantification in red blood
cells using post-column isotope dilution analysis.24 This study
revealed that losses of about 30% were occurring during sample
preparation, specifically during the haemoglobin precipitation
step. One alternative to address such losses is the use of standard
additions, which is feasible in the case of Cu, Zn-SOD since the
human enzyme is commercially available. However, this is a time
consuming and expensive methodology since spiking at 2–3 levels
of concentration have to be conducted.25 Another possibility is
the use of an adequate internal standard. This possibility has
been demonstrated successfully for quantification using ICP-MS
and the capability of this instrument to provide almost species
independent ionization of heteroelements.26 Indeed, the best
results should be obtained if the internal standard were as close in
structure as possible to the sought molecule and if it can be
spiked at the beginning of the sample preparation.25 This is
approximated in protein analysis by using bovine standards
which are often available and relatively affordable.27This journal is ª The Royal Society of Chemistry 2011Thus, in this work we explored the possibility to conduct the
determination of Cu, Zn-SOD in human red blood cells by using
a bovine Cu, Zn-SOD as internal standard. Also the possibility
of using species-specific spiking mode of isotope dilution analysis
(‘‘the perfect internal standard’’) will be evaluated and both
strategies critically compared.
Materials and methods
Reagents, Materials and Samples
Cu, Zn-SOD from bovine was purchased from Sigma-Aldrich
(St. Louis, MO, USA). Mobile phases for HPLC containing: A)
10 mM tris-aminomethane (Merck, Darmstadt, Germany)/
Acetic acid (Merck), pH 7.4 and B) A + 250 mM ammonium
acetate (Merck) were prepared by dilution of the solid salts with
the 18 MUcm distilled de-ionized water (Millipore, Bedford,
MA, USA). Isotopically enriched Cu and Zn solutions with
relative abundances of 98.54% 65Cu and 85.99% 68Zn were
prepared by dilution in water of the stock solution (604.4 mg g1
of Cu and 1009.8 mg g1 of Zn) obtained from Spectrascan
(Teknolab A.S. Dr€obak, Norway). Cut-off membrane filters
(10 KDa) were obtained from Amicon-Ultra (Millipore Iberica,
Madrid). The Bovine samples were provided from a farm and
extracted by a veterinarian and the human samples were
provided by Hospital Central of Asturias (Spain).
HPLC-ICP-MS
HPLC separations were carried out using a dual piston liquid
chromatographic pump (Shimadzu LC-10AD, Shimadzu
Corporation, Kyoto, Japan) equipped with a sample injection
valve Rheodyne, Model 7125 (Cotati, CA, USA), fitted with
a 50 mL injection loop, an anion-exchange column, Mono-Q HR
5/5 (50 5 mm id, Pharmacia, Amersham Bioscience, Spain) and
a Diode Array Detector (DAD) from Agilent Technologies (1100
Series, Waldbron, Germany). All the mobile phases were passed
through a scavenger column (25 0.5 mm id) placed between the
pump and the injection valve in order to eliminate possible metal
traces present as contamination in the mobile phases. The scav-
enger column was packed with Kelex-100 (Schering, Germany)
impregnated silica C18 material (20 mm particle size) (Bondapack,
Waters Corporation, Massachusetts, USA). Specific atomic
detection of Cu and Zn in the column effluent was performed
using an inductively coupled plasma mass spectrometer Model
7500 from Agilent Technologies (Agilent, Tokyo, Japan)
equipped with a collision cell system (ICP-(ORS)-MS).
Preparation of the isotopically enriched Cu, Zn-superoxide
dismutase
The isotopically enriched SOD was prepared using a combina-
tion of previously reported methods by Deitrich et al.17 and
Yamazaki et al.28 In brief, the commercial protein standard
(either human or bovine) was dissolved in 10 mM ammonium
acetate pH 6.3. These stock solutions were then transferred into
3-mL dialysis membranes with a 5000 Da molecular weight cut-
off (MWCO) (Spectra/Pro CE Flot-A-Lyzer, Spectrum Europe
B.V.). Enzyme solutions were dialyzed against a 20 mM
ammonium acetate buffer (pH 6.3) for 1 h at room temperature
to remove low molecular weight impurities in order to obtainJ. Anal. At. Spectrom., 2011, 26, 150–155 | 151
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View Onlinea purified stock solution. For preparation of the apo-enzyme, the
solution was dialyzed against 20 mL of 20 mM ammonium
acetate buffer (pH 3.1) containing 5 mM EDTA for 2h. Then, the
dialysis buffer was changed to a 20 mM ammonium acetate
buffer (pH 3.1) without EDTA (to remove the EDTA). After 2 h,
the dialysis buffer was replaced with 20 mM ammonium acetate
buffer (pH 6.8) and allowed to stand for 1 h, giving the apo-
enzyme solution. The structure of the apo-enzyme was confirmed
by MALDI-TOF (Voyager-DETM STR BiospectrometryTM
Workstation, Applied Biosytems, Langen, Germany) and by
ESI-MS (LC/MSD Trap System, Agilent Technologies,
Waldbron, Germany).24
The resulting apo-enzyme solution was then remetallated with
the isotopically enriched 65Cu and 68Zn solutions. For incorpo-
ration of the isotopically enriched metals into the apo-enzyme,
an excess of 68Zn and 65Cu solutions were added sequentially at
different pH. First, the Zn2+ ion solution (100 mL of 1009.8 mg
mL1, pH 3.9) was added to the apo-enzyme solution and incu-
bated at 37 C for 4 h, thereafter mixed with the Cu2+ ion solution
(250 mL of 604.4 mg mL1, pH 8.2) and incubated at 37 C
overnight. Afterwards, the remetallated SOD1 was passed
through 10 KDa cut-off filter and thoroughly washed with Milli-
Q water to remove the excess of Cu and Zn. Finally the structure
of the labeled species was confirmed by MALDI-TOF (intact
protein analysis and trypsin digested protein). For trypsin
digestion, 50 mL of the sample were treated with 50 mL urea
(prepared 12 mol L1 in 0.1 mol L1 Tris-HCl) and 5 mL
dithiotreitol (DTT, 0.2 mol L1) to reduce the protein disulfide
bonds. The mixture was centrifuged for 1 min at 700 g and was
left to react for 1 h at room temperature. After this time, 20 mL of
iodoacetamide (IAA, 0.2 mol L1) were added in order to protect
SH groups and the mixture was left to stand for one hour at room
temperature. Finally, 20 mL more of DTT were added to
consume the excess of IAA and after one hour 775 mL of Milli-Q
water and 100 mL trypsin were incorporated. This cocktail was
kept for 15 h at 37 C and then the pH adjusted at about 6 with
acetic acid. The peptides obtained with this procedure were then
cleaned by Zip-Tip 18 and immobilized in the MALDI plate
using a-ciano as matrix. The sequence coverage of the obtained
peptides was 99%.Fig. 1 Copper profile by HPLC-ICP-MS corresponding to a mixture of
a standard of bovine SOD1 (A) and human SOD1 (B) in an approxi-
mated ratio of 1 : 1 (400 ng ml1 as Cu or 100 mg mL1 as SOD).
Table 1 ICP-MS and HPLC operating conditions used in the work
ICP-MS Parameters
Instrument Agilent 7500 CE (ORS)
Rf power 1500 W
Nebulizer gas flow rate 1 L min1
m/z monitored 63Cu, 65Cu
Hexapole bias 15 V
QP bias 13 V
HPLC Parameters
Column Mono Q HR 5/5 Anion exchange
Injection volume 50 mL
Flow rate 1 mL min1
Mobile phases A) 10 mM Tris-Acetic Acid B) A +
250 mM ammonium acetate
Gradient Gradient 0–100% B in 30 min
(linear)Real sample treatment
Bovine red blood cells and human red blood cells, collected with
sodium citrate as anticoagulant, were hemolyzed by addition of
ice cold distilled water (4.5 mL per 0.5 mL of cells) and shaking
for 3 min using a vortex mixer at room temperature. After that
a solution of ethanol–chloroform (2 : 1) (3.75 mL per 0.5 mL of
cells) was added in order to accomplish the haemoglobin
precipitation. After manual shaking for 5 min, the mixture was
centrifuged (12000g, 4 C, 1 h). At last, the samples were passed
through a 10 KDa cut-off filter for cleaning and preconcentra-
tion. In the case of using bovine SOD as internal standard to
quantify the SOD in human red blood cells, an aliquot of the
bovine Cu, Zn-SOD standard was added to the human sample of
red blood cells after lysis and the sample treatment protocol was
then followed. The results obtained for SS-IDA-ICP-MS were
done in bovine red blood cells as proof of concept. For this
purpose, an aliquot of the isotopically enriched SOD standard152 | J. Anal. At. Spectrom., 2011, 26, 150–155from bovine erythrocytes was added to the sample of bovine red
blood cells after lysis and the previously described sample
protocol was followed. For the calculation mass bias has been
corrected by using the exponential model and dead time
corrections are not necessary since the instrument performs
automatic dead time correction.Results and discussion
The use of bovine Cu, Zn-SOD as internal standard for human
SOD1 analysis
A good internal standard should fulfil a number of prerequisites:
1) it should be as similar to the analyte in structure as possible; 2)
the retention time in the chromatographic system should be as
close as possible to the retention time of the analyte when an
elution gradient has been used (thus, nebulization/ionization
effects due to changes in the mobile phase composition can be
addressed); and 3) it should be absent from the sample and
chromatographically separated from interfering compounds. In
this work we have evaluated the possibility of using Cu, Zn-SOD
from bovine erythrocytes as an internal standard for the quan-
tification of the SOD1 extracted from human erythrocytes. For
this purpose, the first step was the evaluation of the chromato-
graphic set-up for the separation of the two investigated stan-
dards (bovine and human standards of SOD1) under the usedThis journal is ª The Royal Society of Chemistry 2011
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View Onlinechromatographic conditions. Fig. 1 shows the obtained
chromatogram for a mixture 1 : 1 of both species injected into
the HPLC-ICP-MS system (the separation conditions are
collected in Table 1). As can be seen, two main species can be
observed in the 63Cu trace at 19 and 21 min, respectively. By
injecting the individual compounds it was possible to realize that
the first eluting peak (19 min) corresponds to the bovine standard
while the one at 21 min corresponds to the human standard. Such
good separation is due to the different isoelectric points of bovine
(4.95) and human (4.75) Cu, Zn-SOD associated to the slightly
different amino acid sequence. The small impurity eluting
between both peaks at approximately 20 min belongs to the
bovine standard and could always be detected. Once the sepa-
ration between both standards was achieved, the next step was
the evaluation of SOD1 from bovine erythrocytes as internal
standard for quantification of human SOD1.
For this purpose, two independent aliquots of the human
erythrocytes lysate (5 mL) were taken and one of them was
spiked with the bovine SOD1 standard (100 mL of 0.05 mg mL1
as SOD). The obtained results are shown in Fig. 2 where it is
possible to observe a good separation between species in the
extracted sample without addition of internal standard (Fig. 2A,
black trace) with the main peak (at 21 min) corresponding to the
retention time of human erythrocytes SOD1. Fig. 2B (blue trace)
shows the resulting chromatogram after spiking bovine SOD1Fig. 2 Copper signal of the SOD1 extracted from human red blood cells
by HPLC-ICP-MS before spiking (A) spiked after lysis with 100 mL of
0.05 mg mL1 bovine SOD (B) and spiked twice: after lysis and at the time
of injection with bovine SOD1 at the same concentration (C).
This journal is ª The Royal Society of Chemistry 2011immediately after the lysis. In this case, the bovine standard
expected to elute at 19 min can be barely detected while a new
unknown Cu-containing species appears at 20 min (not present in
the original sample chromatogram of Fig. 2A). In order to verify
a possible shift on the retention time of the bovine standard due
to the sample matrix, the same sample of Fig. 2B was spiked
again with the bovine standard and re-injected in the chro-
matographic system. The resulting profile is shown in Fig. 2C
where a good separation of the three species could be observed at
19, 20 and 21 min respectively. These initial results pointed out
a possible species degradation of the bovine standard during
sample preparation, since the human SOD1 present in the sample
(eluting at 21 min) showed very similar intensity in all the
obtained chromatograms.
Therefore, this approach could be used for quantification only
if the species degradation occurs to the same extent in the SOD
from the sample and from the standard that does not seem to be
this case. Since this fact has not been confirmed, these results
prove the limited capability of using bovine SOD1 standard as an
internal standard to quantify the SOD in human real samples.
Therefore, the alternative strategy of species specific isotope
dilution was evaluated further on.Species-specific isotope dilution for human SOD1 analysis
The first part of the study was devoted to the optimization of the
synthesis of the labeled species by combining previously pub-
lished methodologies as described in the procedures section.17,28
Fig. 3 shows the chromatographic profiles of the isotopes 63Cu
and 65Cu of isotopically enriched SOD from bovine erythrocytes.
The study was done first by using the bovine SOD1 standard
since it can be obtained as lyophilized powder at higher
concentration that the human standard. After the conditions
were optimized, the remetallation protocol was also applied to
the human SOD1 (data not shown). The signals of remetallated
enzyme shown in Fig. 3 revealed an altered isotopic abundance
when compared with those of natural standard of Cu, Zn-SOD
and the isotope ratio is 63Cu/65Cu ¼ 0.015  0.002 (similar to theFig. 3 Chromatogram of the isotopically enriched bovine SOD1
obtained in the laboratory for the two copper isotopes and the corre-
sponding isotope ratio on the SOD1 peak (250 mg mL1 SOD obtained by
dilution of the synthesized standard).
J. Anal. At. Spectrom., 2011, 26, 150–155 | 153
Fig. 4 Chromatogram of the extracted SOD1 from bovine red blood
cells by HPLC-ICP-MS after spiking with isotopically enriched bovine
SOD1 right after lysis and used for quantitative purposes (approximately
10 mg mL1 as SOD). Red trace is off-axes (10000 cps) for clarity.
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View Online65Cu standard used for the enrichment). It is important to
observe that the demetallation–remetallation process has not
degraded the protein since no other species can be seen in the
chromatogram.
The quantification of the bovine standard of isotopically
enriched SOD1 was achieved by reversed post-column isotope
dilution analysis using the previously developed procedure.24 For
this purpose a solution containing 20 ng mL1 of natural Cu
(63Cu, 69.15%) was continuously pumped by an arm of a T piece
and mixed with the eluent coming from the chromatographic
column. After calculating the isotope ratio on each point of the
chromatogram and applying the on-line isotope dilution equa-
tion (ESI†), it is possible to obtain the mass flow chromatogram
and calculate the ng of Cu associated to the main peak in the
chromatogram. This permits the indirect quantification of the
SOD concentration provided that the metal/protein stoichiom-
etry is maintained along the whole procedure (input quantities
for the calculation are given in the ESI†).24,25 The concentration
obtained was 0.17  0.01 mg mL1 of Cu (2.7 mM) (n ¼ 3
injections of the diluted synthesized standard) for the isotopically
enriched SOD1. Metal concentrations can be converted into
protein concentrations since the stoichiometry of the protein–
metal complex is known for both metals (ratio of 2 : 1 metal per
protein). Therefore, the final concentration of isotopically
enriched SOD1 is 43.5  2.6 mg mL1 (1.36 mM) (n ¼ 3 injec-
tions). Additional experiments for spike characterization by
activity measurements were not conducted since Cu has proved
to be quantitatively recovered from the column and it is the
catalytic center of SOD.24
In order to address if possible metal exchange between species
(natural and isotopically labelled) we initially mixed the natural
SOD1 standard from bovine erythrocytes (previously quantified
by post column IDA) with the isotopically labelled synthesized
species in an approximated 1 : 1 ratio. Together with metal
exchanging, this experiment can be also used to corroborate the
method accuracy by calculating the concentration of the natural
SOD1 by species specific IDA. The concentration of Cu in the
natural standard of SOD1 by this method was determined to be
about 1.72 0.06 mg mL1 (27 mM or 436 mg mL1 SOD) (n¼ 3
injections), a value which agrees well with the concentration
obtained for the same standard by post-column IDA (1.74 0.03
mg mL1 Cu, n ¼ 3 injections). Therefore we have proven that it
should be possible to use this SOD isotopically enriched in 65Cu
for the quantification of the SOD in bovine real samples since no
isotopic exchange between SOD1 species can be observed. The
analytical performance characteristics of the SS-IDA method are
summarized in Table 2 and compared with those provided by
ELISA assay. It is noteworthy that ELISA provides better
sensitivity than the proposed strategy although the linear
dynamic range of the SS-IDA method makes it more suitable forTable 2 Analytical features of the proposed SS-IDA method for Cu, Zn-SO
Method LODa/ng ml1 LOQa/ng mL1 %
SS-IDA HPLC-ICP-MS 100 800 2
ELISA 0.04 0.2 3
a Expressed as concentration of SOD.
154 | J. Anal. At. Spectrom., 2011, 26, 150–155analysis of SOD1 in red blood cells (with concentration levels in
the ppm range). In the case of serum, where the reported SOD1
concentrations are in the ng mL1, the ELISA assay could be
more suitable.
Once we proved that the isotopically enriched SOD could be
used as a standard for species-specific IDA-ICP-MS, we applied
this compound to quantify the concentration of SOD1 in
erythrocytes extracted from a cow blood sample. For this aim,
the isotopically labeled spike is added to the cells right after lysis
and the sample processed as described in the sample treatment
section. The mixture is then injected in the HPLC-ICP-MS
systems. The copper chromatogram obtained is shown in Fig. 4
and as can be seen, no species degradation seems to be observed
(differently to the case of using bovine SOD1 as internal standard
for human SOD1). After application of the species specific
isotope dilution equation (shown in the ESI†) to the peak areas
in the chromatogram, the final concentration of Cu in the sample
turned out to be 19.05  0.03 ng mL1 (31 mM or 4.83 mg mL1
as SOD) (n ¼ 3 injections) or 18  1 ng mL1 (n ¼ 3 independent
lyses). Similarly, the SOD1 from the cow red blood cells was
quantified by means of post-column IDA. In this case the Cu
obtained results (13.62  0.02 ng mL1 or 3.46 mg mL1 as SOD,
n¼ 3 injections) are lower than those obtained by species-specific
IDA. Since the column recovery has proved to be quantitative
for Cu and for Cu-SOD (but not for Zn) in previous studies,24 the
losses (about 30%) might occur during hemoglobin precipitation
and sample preconcentration steps. In any case, the obtained
results corroborate the IDA principle that the earlier the spike is
mixed with the sample, the more errors along the sample prep-
aration/isolation can be compensated.D quantification compared with ELISA assays for the same analyte
RSD (3 injections) %RSD (3 lysis) Linear range/ng mL1a
10 100–5000
5 0.08–5
This journal is ª The Royal Society of Chemistry 2011
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View OnlineConclusions
Two different strategies have been evaluated for quantification of
Cu, Zn-SOD in red blood cells. The first one makes use of the
bovine SOD species as an internal standard to quantify the
human SOD1. Such a method has proved to be feasible (without
observing species degradation) when the sample and the spike are
mixed just before injection in the chromatographic system.
However, when the spiking is conducted at the beginning of the
sample treatment procedure, specific degradation of the bovine
species used as standard with respect to the human SOD can be
observed with time. Therefore, the next step was the evaluation
of using the same species as internal standard but isotopically
enriched and then species specific isotope dilution analysis. In
this regard, the optimization of the isotopically enriched species
synthesis permitted to obtain a fairly pure isotopically labelled
standard of bovine SOD1 to be used for further quantitative
studies. The SS-ID-ICP-MS allow the quantitative determina-
tion of Cu, Zn-SOD in real red blood cells of bovine samples and
compensate for loses during sample preparation that turned out
to be of about 30% of the total SOD1. Since lysis is a process that
affects cell walls, the fact of adding the protein spike (already
solubilised) before or after lysis does not affect the protein
recovery from the sample. On the other hand, once the protein
from the red blood cells is solubilised in the water media and the
spike solution of isotopically enriched SOD is added, both
species have proved to behave in the same way. Such results are
in agreement with previous standard addition measurements in
human SOD1 that revealed that while the chromatography used
was fully quantitative the rest of the sample preparation steps
were somehow prone to losses. In any case, the appropriate use
of the species specific IDA method could be compared with
AQUA strategies. However, a very important difference is that
AQUA peptides are added into the sample after tryptic digestion
of the protein to the corresponding peptides, thus, any losses of
the procedure before this point can not be taken into account.
When using SS-IDA, the spiking can be done right after lysis (or
even before) and thus, all the losses during sample handling will
have an affect in the same way on the sample protein and the
spike and will therefore, be compensated.
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